发明名称 Compositions and methods for topical diagnostic and therapeutic transport
摘要 Compositions and methods are provided that are useful for the delivery, including transdermal delivery, of biologically active agents, such as non-protein non-nucleotide therapeutics and protein-based therapeutics excluding insulin, botulinum toxins, antibody fragments, and VEGF. The compositions and methods are particularly useful for topical delivery of antifungal agents and antigenic agents suitable for immunization. Alternately, the compositions can be prepared with components useful for targeting the delivery of the compositions as well as imaging components.
申请公布号 US8974774(B2) 申请公布日期 2015.03.10
申请号 US200510591486 申请日期 2005.03.03
申请人 Revance Therapeutics, Inc. 发明人 Dake Michael D.;Waugh Jacob M.
分类号 A61K31/74;A61K39/00;C07K14/00;C07K7/00;C07K17/08;A61P17/00;A61K47/48;A61K49/00 主分类号 A61K31/74
代理机构 King & Spalding LLP 代理人 Sonnenfeld Kenneth H.;Eng, Jr. Joseph D.;King & Spalding LLP
主权项 1. A method of administering a biologically active protein to a subject in need thereof, the method comprising topically applying to the skin or epithelium of the subject a composition comprising a biologically active protein and a positively charged carrier in an effective amount for transdermal delivery of the biologically active protein, wherein the positively charged carrier comprises a polypeptide having attached thereto positively charged efficiency groups comprising (i) amino acid sequences selected from the group consisting of -(gly)n1-(arg)n2 (SEQ ID NO. 1), wherein the subscript n1 is an integer of from 0 to about 20, and the subscript n2 is independently an odd integer of from about 5 to about 25; (gly)p-RGRDDRRQRRR-(gly)q (SEQ ID NO. 2), (gly)p-YGRKKRRQRRR-(gly)q (SEQ ID NO. 3), and (gly)p-RKKRRQRRR-(gly)q (SEQ ID NO. 4), wherein the subscripts p and q are each independently an integer of from 0 to 20; or (ii) Antennapedia protein transduction domain (PTD) peptide, wherein the biologically active protein excludes insulin, vascular endothelial growth factor (VEGF), and antibody fragments; wherein the composition does not comprise a negatively charged backbone; and wherein the positively charged carrier and the biologically active protein non-covalently and directly associate.
地址 Newark CA US